The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech is completely an OFS of 2.09 crore equity shares up, aggregating up to Rs 1,551 crore.
Standard deviation studies pointing Nifty at 25,000 and beyond: Anand James
Anand James of Geojit Investments sees potential for Nifty to hit 25,000, though warns that a drop below 24,280 may signal weakness. He expects defence